These findings could enable the acquisition of data on the VHL expression via CT/MR imaging approaches and could be applied for the development of targeted therapy, aiming to achieve the imaging signatures of tumor genomics that can aid in identifying patients who benefit from specific targeted therapies. This evidence concerns the gene VHL and neoplasm.